| abstract |
Binding molecules such as TCR or antigen-binding fragments thereof and antibodies and antigen-binding fragments thereof, such as those that recognize or bind to human papillomavirus (HPV) 16, including HPV16 E6 and HPV16 E7, are provided. Also provided are engineered cells containing such binding molecules, compositions containing the binding molecules or engineered cells, and methods of treatment, eg, administering the binding molecules, engineered cells, or compositions. |